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Abstract Some neuropatbological changes characteristic of 
aging and Alzbeimer’s disease (AD) in humans are present also 
in senescent non-human primates. The human apoE allele is 
associated with an increased risk of developing late-onset familial 
and sporadic AD. We found that rhesus monkeys and three sub- 
species of squirrel monkeys are bomozygous for apoE phenotype 
with arginine at positions 112 and 158 as in human apoE4. How- 
ever, in both species threonine replaces arginine at position 61 of 
human apoE. It was previously shown that arginine 61 was critical 
in determining apoE lipoprotein distribution in humans. 
Key tuords: Aging; Alzheimer’s disease; Amyloid; 
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1. Introduction 
Sporadic and inherited cerebral amyloidoses are character- 
ized by the deposition of /?-amyloid (A/?) fibrils, which are 
formed by aggregation of a fragment of a larger P-amyloid 
precursor protein (/?PP) [l&7], predominantly in the extracellu- 
lar space of the brain parenchyma. Patients with sporadic cer- 
ebral amyloid angiopathy (SCAA), hereditary cerebral hemor- 
rhage with amyloidosis, Dutch type (HCHWA-D) and some 
patients with familial Alzheimer’s disease, display vascular syn- 
dromes ranging from multiinfarct dementia to single massive 
intracerebral hemorrhages, as a result of extensive amyloid 
deposition within cerebral vessel walls [S-16]. 
Similar to humans, aged non-human primates manifest A,B 
deposits in the cerebrum and the amount and localization of 
amyloid varies among individuals of similar age [17-191. In 
aged rhesus monkeys (Mucaca mulatta), Old World primates 
with a life span of 35540 years [20], cerebral amyloid deposition 
occurs most commonly in association with senile plaques and 
less frequently in blood vessels. These aged monkeys exhibit 
behavioral abnormalities that are similar to the minor cognitive 
deficits manifested by aged humans [21]. Conversely, in aged 
squirrel monkeys (Saimiri sciureus), New World primates with 
a life span of 25-30 years [ 181, cerebrovascular deposits usually 
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are more conspicuous than are senile plaques [l&22]. In the 
brains of all aged squirrel monkeys tested amyloid was associ- 
ated primarily with intracerebral and meningeal capillaries and 
arterioles and occurs to a lesser degree as senile plaques [18]. 
Vascular amyloid deposition is an age-associated process, with 
marked differences in the degree of vascular amyloidosis and 
the incidence of non-vascular lesions between monkeys of the 
same chronological age [ 18,221. The brains of aged rhesus mon- 
keys as well as squirrel monkeys lack neurofibrillary tangles, 
another neuropathological hallmark of AD in humans. 
Apolipoprotein E (apoE) is a plasma protein that, in the 
human population, presents three major alleles (e2, e3 and e4) 
which encode three apoE isoforms (E2, E3 and E4) [23]. The 
e4 allele is associated with an increased risk of developing AD 
in late-onset familial as well as sporadic AD [2428]. Using 
two-dimensional polyacrylamide-gel-electrophoresis it was 
shown that ninety non-human primates of nine different spe- 
cies, including squirrel monkeys (12 monkeys), have a homozy- 
gous apoE phenotype, which in accordance with the human 
nomenclature was designated E3/E3 [29]. However, PCR anal- 
ysis revealed the apoE allele in rhesus monkey to resemble the 
human apoE isotype [30]. To clarify this issue, we compared 
the apoE isotype in rhesus monkeys and three subspecies of 
squirrel monkeys to test the hypothesis that species differences 
and inter-individual variability in the histological locus of amy- 
loid deposition are related to the apoE allelotype in non-human 
primates. 
2. Materials and methods 
2.1. Tissues 
DNA was isolated from frozen tissues of nine squirrel monkeys of 
unknown subspecies and from blood and frozen liver tissues of 30 
monkeys from The Primate Research Center at the University of South 
Alabama (10 squirrel monkeys of each of 3 distinct phenotypes: Saimiri 
boliviensis, Saimiri sciureus and Saimiri boliviensis peruviensis). DNA 
was also isolated from blood of four rhesus monkeys, and from a 
human with known apoE phenotype. 
2.2. APOE genotyping 
APOE genotyping was performed as previously described 131,321. 
Genomic -DNA -was isolated by the phenol/chloroform extraction 
method [33]. DNA fragments of 227 bp, which span both apoE human 
polymorphic sites, were PCR-amplified using the primers underlined 
with a double line (Fig. l), and were digested with HhaI. Digestion 
products were analyzed on 10% PAGE, stained with ethidium bromide 
and viewed under UV light. These fragments, as well as fragments that 
were PCR amplified using the primers underlined with a single line (Fig. 
l), were sequenced. For sequence analysis, 1 ,ul of amplified fragments 
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Fig. 1. Nucleotide sequence of squirrel monkey (sm) APOE cDNA, 
shown in the first line. Nucleotide substitutions found in human (hu) 
and in rhesus monkey (rm) are indicated in the second and third lines, 
respectively. Numbering according to the human amino acid sequence. 
residue residue residue 
61 112 158 
++ 4 
human apoE I Arx CF cys 
human apoE I Arx CP Arx 
human apoE Arx Arx Arx I 
squirrel monkey apoE Thr Arx Arx 
rhesus monkey apoE Thr Arx Arx 
Fig. 2. Diagram of allelic variants of apoE. The amino acid sequences 
at residues 61, 112 and 158, according to the human numbering and 
nomenclature, are indicated. 
was cloned into pCRI1 vector (Invitrogen, San Diego, California). 
Several colonies, derived from at least two unrelated PCR reactions, 
were sequenced by the dideoxy chain termination method with se- 
quenase (USB) and the sequence was determined in both strands. 
3. Results and discussion 
Allelic polymorphism in the human APOE gene results in 
three major isoforms. The E2 isoform differs from the E3 
isoform by an Arg to Cys substitution at position 158. The E4 
isoform differs from the E3 isoform by a Cys to Arg substitu- 
tion at position 112 (Fig. 2). The nucleotide substitutions that 
account for the allelic variation result in polymorphic restric- 
tion sites for HhaI. All squirrel monkeys tested showed the 
same arrangement of bands, different from that of rhesus mon- 
keys and humans (Fig. 3). Sequence analysis of the PCR-ampli- 
fied APOE DNA fragments revealed the sequence differences 
between the squirrel monkey, the rhesus monkey and the 
human (Fig. 1) that are responsible for the difference in the 
restriction patterns. Within the DNA fragment sequenced, the 
squirrel monkey’s APOE sequence differs from the human se- 
quence by 18 nucleotides. The rhesus monkey’s sequence differs 
from that of the human by 15 nucleotides, 8 of which are 
identical to the squirrel monkey’s sequence. The first nucleotide 
of codon 93 of the rhesus monkey’s sequence is polymorphic, 
but does not result in an amino acid change. 
Both rhesus and squirrel monkeys are homozygous for 
apoE with Arg at positions 112 and 158, according to the 
human numbering and nomenclature. Eight deduced amino 
acid differences between the squirrel monkey and human se- 
quences were found, five of which are shared with the rhesus 
monkey: Arg6’Thr, Thr83Ser, Gly’13Ser, Gly’20Ser, Val”‘Ala. 
Three differences are unique to the squirrel monkey: Val”6Ala, 
Gl~‘~‘Asp and Ala’52Val, and two differences are unique to the 
rhesus monkey: Ser54Pro and Ala62Thr. We have analyzed a 
large sample of squirrel monkeys, searching for possible sub- 
species or individual differences in APOE genotype that could 
be responsible for the variability in amyloid deposition found 
in these monkeys. However, the APOE genotype in all monkeys 
tested was identical. 
In humans the E3 allele, with Cys at position 112, is the most 
common. The apoE proteins of the squirrel monkey, rhesus 
monkey [30], cynomolgus monkey [34], baboon [35], cow [36], 
pig [37], rat [38] and mouse [39] all contain an Arg at this 
residue. The rabbit apoE contains a Cys at residue 112 [40]. The 
Cys-Arg interchange at position 112, which distinguishes 
apoE from apoE4, influences the class of lipoprotein to which 
the carboxyl-terminal domain will bind; apoE displays a pref- 
erence for high density lipoproteins and apoE for very low 
density lipoproteins. The involvement of Arg” in modulating 
domain interaction appears to be a key factor in determining 
the isoform-specific lipoprotein preferences of apoE [41]. Of the 
ten animal species for which the sequence of apoE is known, 
only human apoE has an arginine at position 61; all of the other 
species, including rhesus and squirrel monkeys, contain threon- 
ine at this position (or its equivalent) (Fig. 1). When the Arg61 
in the human apoE was mutated to threonine, the binding 
preference of apoE shifted from very low density lipoproteins 
bp 
lee - 
72 P 
58 P 
hu sm sm rm 
Fig. 3. APOE genotyping of human and monkeys DNA by Hhal re- 
striction fragment analysis of PCR products. The patterns of human 
APOE3/E2 (hu), two squirrel monkeys APOE (sm) and a rhesus mon- 
keys APOE (rm) are presented. The 100, 72 and 50 bp markers are 
marked by arrowheads. 
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to high density lipoproteins [41]. It is therefore likely that the 
apoE in the monkeys behaves like human apoE3, at least with 
regard to its interaction with lipoproteins. 
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